Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administration.
about
Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administration.
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Occurrence of adverse events c ...... ed by low-dose administration.
@ast
Occurrence of adverse events c ...... ed by low-dose administration.
@en
type
label
Occurrence of adverse events c ...... ed by low-dose administration.
@ast
Occurrence of adverse events c ...... ed by low-dose administration.
@en
prefLabel
Occurrence of adverse events c ...... ed by low-dose administration.
@ast
Occurrence of adverse events c ...... ed by low-dose administration.
@en
P2093
P2860
P356
P1476
Occurrence of adverse events c ...... ed by low-dose administration.
@en
P2093
A Shigematsu
K Fujimoto
M Takahata
P2860
P304
P356
10.1111/TID.12456
P577
2015-09-09T00:00:00Z